BioSpace News Archive

Today, Octant announced the appointment of Mark Murcko as Strategic Advisor and Board Member.

Kriya Therapeutics, Inc. , a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today announced the appointment of Theresa Heah, M.D., MBA as Chief Medical Officer.

Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today announced that it expects to release its third quarter financial results for the period ended September 30, 2021, on Thursday, Oct. 28, after market close.

Gan & Lee Pharmaceuticals Co., Ltd. is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic.

NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces preclinical data for NLS-4, the Company’s next-generation wake-promoting drug candidate, which has shown promise for the treatment of chronic fatigue associated with Long-COVID.

Lirio, whose Precision Nudging™ solution promotes health through AI-powered behavior change, today announced the launch of a new Precision Nudging solution to encourage people to schedule and attend colorectal cancer screenings with their healthcare providers.

MJH Life Sciences™ is excited to announce AdvanCE, formerly run by Drug Topics, has officially launched as its own stand-alone brand. AdvanCE is an Accreditation Council for Pharmacy Education (ACPE)-accredited subscription service for pharmacists and pharmacy technicians to enhance their clinical, operational, and leadership skills.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, October 29, 2021 to discuss its third quarter operating results

CTI BioPharma Corp. announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employee’s acceptance of employment with the company.

MiMedx Group, Inc., an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, announced that it will host a virtual Investor Day on Tuesday, December 7, 2021 beginning at 9:00 a.m. ET.